UM
(Note: the search results are based on claimed items)

Browse/Search Results:  1-3 of 3 Help

Filters                
Selected(0)Clear Items/Page:    Sort:
China’s landscape of discovering miRNAs in cancer Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 73-90
Authors:  Hengwa Kuok;  Xiangjun Kong;  Yuanjia Hu;  Yitao Wang
Favorite  |  View/Download:4/0  |  Submit date:2019/01/14
Collaboration networks for R&D of monoclonal antibodies: An analysis based on pipeline projects Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 135-158
Authors:  Tianhong Yin;  Xiangjun Kong;  Yitao Wang;  Xin Chen;  Yuanjia Hu;  Rong Shao
Favorite  |  View/Download:10/0  |  Submit date:2019/01/14
Monoclonal Antibodies  Research And Development  Network Analysis  Institutional Collaboration Network  Country-based Collaboration Network  
Pharmaceutical patent valuation based on empirical models Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 209-220
Authors:  Jingyun Ni;  Rong Shao;  Carolina Oi Lam Ung;  Yitao Wang;  Yuanjia Hu;  Yong Cai
Favorite  |  View/Download:3/0  |  Submit date:2019/01/14
Pharmaceutical Patents  Patent Value  Valuation  Echnological Factors  Commercial Factors  Legal Factors